PHT 427

(HB1251)

Certificate of Analysis

Latest Certificate of Analysis

Download the latest CoA for this product:

Download CoA

Download Batch-Specific CoA

To download the CoA for a batch, enter the batch ID below:

Technical documents: CoA Datasheet

Product overview

Name PHT 427
Purity >98%
Description Akt / PDPK1 inhibitor
Write Your Own Review
You're reviewing:PHT 427
Rate this item:

Biological Data

Biological description Akt (PKB) and phosphatidylinositol 3-kinase (PDPK1) inhibitor (Ki values are 2.7 and 5.2 µM respectively). Binds at the pleckstrin homology (PH) domain of AKT and PDPK1. Shows anti-tumor and apoptotic actions.

Solubility & Handling

Solubility overview Soluble in DMSO (100mM)
Storage instructions -20°C
Storage of solutions Prepare and use solutions on the same day if possible. Store solutions at -20°C for up to one month if storage is required. Equilibrate to RT and ensure the solution is precipitate free before use.
Shipping Conditions Stable for ambient temperature shipping. Follow storage instructions on receipt.
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >98%
Chemical name 4-Dodecyl-N-1,3,4-thiadiazol-2-yl-benzenesulfonamide
Molecular Weight 409.61
Chemical structure PHT 427  [1191951-57-1] Chemical Structure
Molecular Formula C20H31N3O2S2
CAS Number 1191951-57-1
PubChem identifier 44240850
SMILES O=S(C(C=C1)=CC=C1CCCCCCCCCCCC)(NC2=NN=CS2)=O
InChiKey BYWWNRBKPCPJMG-UHFFFAOYSA-N

References for PHT 427

References are publications that support the biological activity of the product
  • Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor.

    Meuillet EJ et al (2010) Mol Cancer Ther 9(3) : 706-17.
  • In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT.

    Moses SA et al (2009) Cancer Res 69(12) : 5073-81.

2 Item(s)